相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence
Patricia A. Quispe et al.
DRUG DISCOVERY TODAY (2022)
FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation
Kyuho Jeong et al.
CARDIOVASCULAR RESEARCH (2022)
Targeting EZH2 as cancer therapy Comment
Shunsuke Hanaki et al.
JOURNAL OF BIOCHEMISTRY (2021)
Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network
Lingyuan Zhang et al.
MOLECULAR CARCINOGENESIS (2021)
FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs
Billie G. C. Griffith et al.
SCIENTIFIC REPORTS (2021)
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins
Ryosuke Shirasaki et al.
CELL REPORTS (2021)
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Ilaria Romito et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
Damiano Cosimo Rigiracciolo et al.
CANCERS (2021)
Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton
Muhamad Mustafa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics
Pengcheng Lv et al.
CURRENT MEDICINAL CHEMISTRY (2021)
A Layered View on Focal Adhesions
Karin Legerstee et al.
BIOLOGY-BASEL (2021)
Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACs
Robert P. Law et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Targeting FAK in anticancer combination therapies
John C. Dawson et al.
NATURE REVIEWS CANCER (2021)
The Methyl-CpG-Binding Domain 2 and 3 Proteins and Formation of the Nucleosome Remodeling and Deacetylase Complex
Gage Leighton et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Computational-based discovery of FAK FERM domain chemical probes that inhibit HER2-FAK cancer signaling
Erik Stahl et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
David E. Gerber et al.
LUNG CANCER (2020)
Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
Konrad Steinestel et al.
MOLECULAR ONCOLOGY (2020)
FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication
Hsin-Jung Wu et al.
ONCOGENE (2020)
FAK Structure and Regulation by Membrane Interactions and Force in Focal Adhesions
Paula Tapial Martinez et al.
BIOMOLECULES (2020)
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials
Atish Mohanty et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
FAK Family Kinases in Vascular Diseases
James M. Murphy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice
Hongying Gao et al.
PROTEIN & CELL (2020)
Structural basis of Focal Adhesion Kinase activation on lipid membranes
Ivan Acebron et al.
EMBO JOURNAL (2020)
Focal Adhesion Kinase (FAK) Over-Expression and Prognostic Implication in Pediatric Hepatocellular Carcinoma
Paola Francalanci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
Yang Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Katherine A. Donovan et al.
CELL (2020)
Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs)
Daniela Tomaselli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
FAK Signaling in Rhabdomyosarcoma
Clara Perrone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression
Kyuho Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Xiaodong Feng et al.
CANCER CELL (2019)
Phase I Study of the Focal Adhesion Kinase Inhibitor BI853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi et al.
TARGETED ONCOLOGY (2019)
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
Maja J. A. de Jonge et al.
TARGETED ONCOLOGY (2019)
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
Gabriel Mak et al.
BRITISH JOURNAL OF CANCER (2019)
Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration
Abdulhameed Al-Ghabkari et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A. Fennell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Focal Adhesion Kinase/β-Catenin Network May Act as a Regulator of Hepatocellular Carcinoma Epigenetics
Ilaria Romito et al.
HEPATOLOGY (2019)
The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
Jin Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Induced degradation of protein kinases by bifunctional small molecules: a next-generation strategy
Jay C. Groppe
EXPERT OPINION ON DRUG DISCOVERY (2019)
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
Laura L. Stafman et al.
SCIENTIFIC REPORTS (2019)
TAE226, a dual inhibitor of focal adhesion kinase and insulin-like growth factor-I receptor, is effective for Ewing sarcoma
Hiroshi Moritake et al.
CANCER MEDICINE (2019)
Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
Frank Aboubakar Nana et al.
CANCERS (2019)
The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma
Viktoria Laszlo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [C-11]GSK2256098
Nicholas F. Brown et al.
NEURO-ONCOLOGY (2018)
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer
Hui-Ming Lin et al.
PROSTATE (2018)
Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice
Shaogang Sun et al.
SCIENTIFIC REPORTS (2018)
Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development
Rayan Naser et al.
CANCERS (2018)
The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
Stefanie Tiede et al.
ONCOGENESIS (2018)
Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
Philipp M. Cromm et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
Janine Wörthmüller et al.
Oncotarget (2018)
VS-4718 Antagonizes Multidrug Resistance in ABCB1-and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
Ning Ji et al.
FRONTIERS IN PHARMACOLOGY (2018)
Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program
Raushan T. Kurmasheva et al.
PEDIATRIC BLOOD & CANCER (2017)
Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma
Nadia Panera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
FAK-Src-paxillin system expression and disease outcome in human neuroblastoma
Panagiotis Kratimenos et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2017)
IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
Bryan Serrels et al.
SCIENCE SIGNALING (2017)
IL-33 and ST2 mediate FAK-dependent antitumor immune evasion through transcriptional networks
Bryan Serrels et al.
SCIENCE SIGNALING (2017)
miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells
Ying Z. Mazzu et al.
CANCER RESEARCH (2017)
Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth
Marta Canel et al.
CANCER RESEARCH (2017)
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2
Daniela Gnani et al.
CELL DEATH AND DIFFERENTIATION (2017)
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
J. C. Soria et al.
ANNALS OF ONCOLOGY (2016)
A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
Toshio Shimizu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)
Gregory R. Ott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors
Timothy A. Marlowe et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells
Alicia M. Waters et al.
TRANSLATIONAL ONCOLOGY (2016)
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
Israa Salem et al.
BREAST CANCER RESEARCH (2016)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Suzanne F. Jones et al.
INVESTIGATIONAL NEW DRUGS (2015)
Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival
Lauren A. Gillory et al.
JOURNAL OF SURGICAL RESEARCH (2015)
PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer
Duangmani Thanapprapasr et al.
MOLECULAR CANCER THERAPEUTICS (2015)
FAK signaling in human cancer as a target for therapeutics
Brian Y. Lee et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The nucleosome remodeling and deacetylase complex in development and disease
Jeannine Basta et al.
TRANSLATIONAL RESEARCH (2015)
Focal adhesion kinase An alternative focus for anti-angiogenesis therapy in ovarian cancer
Rebecca L. Stone et al.
CANCER BIOLOGY & THERAPY (2014)
A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells
Jianliang Zhang et al.
CELL CYCLE (2014)
Targeting FAK in human cancer: from finding to first clinical trials
Vita M. Golubovskaya
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
FAK Inhibition Abrogates the Malignant Phenotype in Aggressive Pediatric Renal Tumors
Michael L. Megison et al.
MOLECULAR CANCER RESEARCH (2014)
EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
Shu-Bin Gao et al.
MOLECULAR CANCER RESEARCH (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells
Ying-Li Hu et al.
SCIENTIFIC REPORTS (2014)
The focal adhesion kinase inhibitor PF-562,271 impairs primary CD4+T cell activation
Andrew J. Wiemer et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Structure-based discovery of cellular-active allosteric inhibitors of FAK
Naoki Tomita et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth
Vita M. Golubovskaya et al.
BMC CANCER (2013)
High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
Brian D. Crompton et al.
CANCER RESEARCH (2013)
Discovery and characterization of novel allosteric FAK inhibitors
Misa Iwatani et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Role of Focal Adhesion Kinase in Regulating YB-1-Mediated Paclitaxel Resistance in Ovarian Cancer
Yu Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins
Jihye Seong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression
Ssang-Taek Lim et al.
JOURNAL OF CELL BIOLOGY (2012)
Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.
U. A. Hirt et al.
MOLECULAR CANCER THERAPEUTICS (2012)
PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments
Isabelle Tanjoni et al.
CANCER BIOLOGY & THERAPY (2010)
Pyk2 Inhibition of p53 as an Adaptive and Intrinsic Mechanism Facilitating Cell Proliferation and Survival
Ssang-Taek Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Anil K. Sood et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The FERM domain: organizing the structure and function of FAK
Margaret C. Frame et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate
Soeren Beinke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
Cedo M. Bagi et al.
CANCER BIOLOGY & THERAPY (2009)
Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2
Shi-Wen Luo et al.
EMBO JOURNAL (2009)
Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271
Walter Gregory Roberts et al.
CANCER RESEARCH (2008)
Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
Sara M. Weis et al.
JOURNAL OF CELL BIOLOGY (2008)
PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility
Yang Lim et al.
JOURNAL OF CELL BIOLOGY (2008)
A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth
Vita M. Golubovskaya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation
Ssang-Taek Lim et al.
MOLECULAR CELL (2008)
Calcineurin is essential for depolarization-induced nuclear translocation and tyrosine phosphorylation of PYK2 in neurons
Camille Faure et al.
JOURNAL OF CELL SCIENCE (2007)
Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53
VM Golubovskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The structural basis of localization and signaling by the focal adhesion targeting domain
ST Arold et al.
STRUCTURE (2002)
分享论文
